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Abstract
Background: From shotgun libraries used for the genomic sequencing of the phytopathogenic bacterium 
Xanthomonas axonopodis pv. citri (XAC), clones that were representative of the largest possible number of coding 
sequences (CDSs) were selected to create a DNA microarray platform on glass slides (XACarray). The creation of the 
XACarray allowed for the establishment of a tool that is capable of providing data for the analysis of global genome 
expression in this organism.
Findings: The inserts from the selected clones were amplified by PCR with the universal oligonucleotide primers M13R 
and M13F. The obtained products were purified and fixed in duplicate on glass slides specific for use in DNA 
microarrays. The number of spots on the microarray totaled 6,144 and included 768 positive controls and 624 negative 
controls per slide. Validation of the platform was performed through hybridization of total DNA probes from XAC 
labeled with different fluorophores, Cy3 and Cy5. In this validation assay, 86% of all PCR products fixed on the glass 
slides were confirmed to present a hybridization signal greater than twice the standard deviation of the deviation of 
the global median signal-to-noise ration.
Conclusions: Our validation of the XACArray platform using DNA-DNA hybridization revealed that it can be used to 
evaluate the expression of 2,365 individual CDSs from all major functional categories, which corresponds to 52.7% of 
the annotated CDSs of the XAC genome. As a proof of concept, we used this platform in a previously work to verify the 
absence of genomic regions that could not be detected by sequencing in related strains of Xanthomonas.
Findings
Citrus canker, or cancrosis, is a disease that affects most
species of the Citrus  genus [1]. Its symptoms can be
observed on leaves, fruits or branches and are character-
ized by small, pointed and spongy pustules that are sur-
rounded by a chlorotic halo on both sides of the leaf. This
halo tends to spread quickly through the tissue, increas-
i n g  i t s  d i a m e t e r  a n d  b e c o m i n g  b r o w n i s h  o r  d a r k e r  i n
color with a rough and salient appearance [2]. The causal
agent of cancrosis is the bacterium Xanthomonas axo-
nopodis  pv.  citri  (XAC) [3], more recently renamed as
Xanthomonas citri subsp. citri [4,5] whose genome was
completely sequenced in 2002 [6] and compared with
others organisms [6-8]. Data from this sequencing proj-
ect revealed that the XAC genome contains a circular
chromosome of 5.2 Mbp and two plasmids (33 and 64
Kbp), containing a total of 4,489 coding regions [6].
To perform the complete sequencing of this phyto-
pathogen, shotgun libraries containing 46,462 clones
were created and distributed over approximately 500 96-
* Correspondence: lmmorei@gmail.com
1 Departamento de Ciências Biológicas (DECBI), Instituto de Ciências Exatas e 
Biológicas, Universidade Federal de Ouro Preto, Campus Morro do Cruzeiro, 
Ouro Preto, MG, Brazil
Full list of author information is available at the end of the articleMoreira et al. BMC Research Notes 2010, 3:150
http://www.biomedcentral.com/1756-0500/3/150
Page 2 of 9
well plates, representing 98% of the genome, with an esti-
mated coverage of seven times its size [6]. The remaining
2% of the genome was sequenced using a cosmid library.
Upon completion of the sequencing project, the clones
were stored with the expectation that they would be use-
ful for future functional genomics studies. We here
explore one of the possible applications of this library,
namely the use of these clones to build a DNA microarray
platform for use in studies of gene expression and geno-
typing [9]. Building on the data provided by the XAC
genome project, this tool will enable the exploration of
the physiological and biochemical machinery of this
organism in distinct environmental situations, both in
vitro and in vivo, thus providing clues to the working of
Xanthomonas metabolism and the mechanisms of infec-
tion and disease.
Clone selection from shotgun libraries
The clones in the XAC sequencing libraries were gener-
ated from total bacterial DNA (chromosomal DNA +
plasmid DNA) using shotgun methods [10] and cloning
into the pUC18 vector. The number of clones totaled
46,462 with inserts ranging in size from 400 to 5,200 bp
(Figure 1AB) [6]. All of these clones were placed in 496
96-well plates, and stored at -80°C. In order to represent
the CDSs in the XACarray, clones that included the larg-
est fragments (0.4 to 3 Kbp) of each CDSs of interest were
selected. However, not all of the CDSs were represented
b y  c l o n e s  t h a t  i n c l u d e d  a  s i n g l e  o p e n - r e a d i n g  f r a m e
(ORF). Actually, many CDSs were represented by clones
that possessed inserts with parts of other CDSs or even
whole CDSs. Thus, the selected clones were divided into
four possible overlap types, considering the sequence seg-
ment of interest in relation to the insert as a whole: I) the
CDS is completely represented within the insert and is
surrounded on both sides by intergenic regions and/or
other CDSs; II) the insert is an internal fragment of the
corresponding CDS; III) part of the interested CDS flank-
ing the left margin of the insert, or IV) part of the inter-
ested CDS flanking the right margin of the insert (Figure
1C). Details of the relationship between the insert and
CDS of interest are described in the results and are sum-
marized in Table 1.
Amplification, purification and identification of PCR 
products
The selected clone inserts were amplified through PCR
after DNA extraction by the boiling preparation tech-
nique [11]. The amplification reactions were performed
with an initial denaturation at 95°C for 5 minutes, fol-
lowed by 40 denaturing cycles at 95°C for 45 seconds,
annealing at 50°C for 30 seconds and extension at 72°C
for 1 minute in a final volume of 50 μL of amplification
solution containing 1.0 μL boiling prep product, 1 U Taq
DNA Polymerase™ (Invitrogen), 40 mM dNTPs (Invitro-
gen) and 10 pmols of each universal oligonucleotide M13
(forward 5'-GTTTTCCCAGTCACGAC-3' and reverse
5'-CAGGAAACAGCTATGAC-3'). In an attempt to
increase the amount of the generated product, 1.0 μL of
the amplification reaction was added to new amplifica-
tion solution with the same volume and concentration of
reagents and submitted to the amplification protocol
described above.
The amplification products were purified with Multi-
screen Millipore™ (cat. # MAFB NOB 50) filters plates
and diluted in 50 μL of 10 mM Tris pH 8.0 directly into
96-well plates. The purification products were then man-
ually combined in 8 384-well plates; one of these plates
contained the hybridization controls (ScoreCard [12]).
In all steps, the PCR products were evaluated by elec-
trophoresis in 1% agarose gels stained with ethidium bro-
mide [13]. Amplicon size and quantity were estimated by
comparison to a molecular weight standard that was cre-
ated specifically for this purpose (Figure 2A). This stan-
dard contained three DNA fragments of 1,697, 689 and
297 bp, respectively, with pre-determined concentrations.
The standard was produced by cleavage of the pUC19
plasmid with the restriction enzymes HindIII, NdeI and
ScaI, respectively, and was purified using a cesium chlo-
ride density gradient column [14]. This strategy allowed
for comparative visual analysis of the sample concentra-
tions in the gels, eliminating the need for individual
quantification of each observed product.
To ensure that each amplified PCR product was in fact
the clone selected for each CDS, an end of the insert in
each of the clones was sequenced using the universal oli-
gonucleotide primer M13R and the BigDye terminator
v3™ kit (Applied Biosystems). These sequences were then
compared to the database of sequencing reads and the
XAC genome using the BLASTn algorithm [15].
Fixation of PCR products onto glass slides
Equal volumes of DMSO were added to the purified PCR
products in 384-well plates so that the final concentration
was approximately 200 to 400 fmol/μL of DNA [16].
Afterwards, DNA was deposited onto Type 7 mirrored
glass slides (Amersham Biosciences/GE Healthcare)
using a robot (Generation  III  Microarrays Spotter™ -
Amersham Biosciences/GE Healthcare). This robot
allowed for the deposition of up to 4,608 DNA samples
that were organized into 12 subsets (subarrays) of 384
spots (12 × 32) (Figure 2A). The set of 3,072 probes,
which corresponded to the products on the 384-well
plates and included positive and negative controls, was
placed in duplicate in the two longitudinal halves of the
slide. The duplicates were called set A and set B, respec-
tively, and constituted a technical replica on each slide
(Figure 2A). After DNA deposition, the slides were sub-Moreira et al. BMC Research Notes 2010, 3:150
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mitted to 50 mJ UV light, which promoted the fixation of
the DNA onto the support. The slides were stored in des-
iccators (relative moisture ~5%), ready to be used for any
experimental purpose.
XAC cultivation and DNA extraction
The XAC 306 isolate was extracted from Citrus limonia
L. Osbeck (rangpur lime)-infected leaves and stored in
30% glycerol at room temperature until use. The strain
was sowed to reactivate its growth in NA solid medium (3
g/L of meat extract, 5/L g of peptone, 5 g/L of sodium
chloride, 15 g/L of agar) and was incubated at 28°C for 48
hours. Samples of the reactivated strain were minced in
12 mL of NA liquid medium in 25-mL Falcon tubes and
maintained under gentle agitation at 28°C for 48 hours.
Appropriated antibiotic was used when necessary. After
this period, the samples were centrifuged for 30 minutes
at 3,000 g at room temperature. The supernatant was dis-
carded, and 12.5 mL of wash buffer (10 mM Tris-HCl, pH
8.8, 3.0 mM KCl, 1.25 mM NaCl) was added to the bacte-
rial pellet. The samples were shaken vigorously using a
vortex and then centrifuged for 15 minutes at 3,000 g at
room temperature. The bacterial pellet was resuspended
again, now using 10 mL of D buffer (25 mM sodium cit-
rate, pH 7.0, 5.0 g/L sarkosyl, 4 M guanidine isothiocya-
nate), and incubated in a 65°C water bath for 1 hour to
promote cell lysis. After the lysis step, 5.0 mL of P buffer
(667 mM Tris-HCl, 833 mM NaCl, 83 mM EDTA, pH
8.0) was added. The solution was shaken by inversion and
centrifuged for 30 minutes at 3,000 g at room tempera-
ture. Aliquots (1.0 mL) of the supernatant were trans-
ferred to tubes with a 2.0 mL capacity, 1.0 mL of
isopropanol was added and the samples were kept at -
20°C. The samples were then homogenized by inversion
and centrifuged for 45 minutes at 3,000 g at 4°C. The
DNA pellet was resuspended, washed twice with 70%
ethanol to promote precipitation and centrifuged for 15
minutes at 3,000 g. Finally, the DNA pellet was resus-
pended in 200 μL TE buffer (10 mM Tris-HCl, pH 8.0, 0.1
mM EDTA) containing 1 μg/mL of RNaseA and incu-
bated for 1 hour at 37°C. The quality and concentration of
the extracted DNA was evaluated on a 0.8% agarose gel
stained with ethidium bromide [14]; the profile of the
band obtained for the DNA samples was compared to a
molecular weight standard with known sizes and concen-
trations (Figure 2A).
Preparation of labeled DNA and microarray hybridization
Double-stranded DNA labeled with fluorophore was pro-
duced by Cy3-dCTP or Cy5-dCTP™ (Amersham Biosci-
ences/GE Healthcare) incorporation during
polymerization from 2 μg XAC total DNA (chromosomal
+ plasmid) that had been fragmented through the shear-
ing technique (~14 times through a syringe with 8 cm and
18 gauge needles) [17]. The reaction was performed using
1 μL of the DNA polymerase Klenow Fragment™ (Gibco)
at a high concentration (40 U/μL) and 500 μg of random
nonamer primers [18]. Afterwards, the labeled DNA was
purified with Multiscreen™ filter plates (Millipore), and
the total amount of incorporated fluorophore was indi-
rectly quantified through absorbance detection at 550 nm
for Cy3 and 650 nm for Cy5. To ensure accuracy in the
analysis, equivalent quantities of fluorescent DNA were
used in the microarray hybridizations, which were per-
formed for 16 hours at 42°C in hybridization buffer
(Amersham Biosciences/GE Healthcare) with 50% forma-
mide. According to protocols described previously by
Koide and coauthors [18], after washing, the slides were
dried by applying a jet of compressed nitrogen gas.
Microarray data was aquired using a Generation III Scan-
ner™ (Amersham Biosciences/GE Healthcare) in order to
obtain images of each fluorescent channel, Cy3 and Cy5,
for each of the microarray probes (Figure 2A).
Detection, quantification and normalization of 
fluorescence signals
After the microarrays were scanned, the crude signal
intensity of the images was determined using Array
Vision 6.0™ software (Image Research/Molecular Dynam-
ics). For each spot on the microarray, which represents a
specific probe, the foreground and background intensity
were measured.
Data preparation included subtraction of the local
noise for each spot, and calculation of average fluorescece
Table 1: Analysis of clone selection grouped according to the overlap models.
Type of clones Total of selected clones Average size of overlap 
Insert/CDS
Average size of non-overlap 
Insert/CDS
I 2055 635 835
II 463 1121 0
III 827 822 418
IV 1124 726 481
Total 4421 830.5a 578b
Note that the average total of the CDS/insert overlap (a) is greater than the average of the non-overlap (b).Moreira et al. BMC Research Notes 2010, 3:150
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Figure 1 (A) Size distribution of the 46,462 inserts generated by the shotgun technique and of the 4,489 CDSs annotated in the XAC ge-
nome. (B) Distribution of the 4,421 selected clones, which best represented 3,084 CDSs of the XAC genome. Note in both figures that for the 
CDSs that were 0 to 200 bp in length and for a small fraction of genes that were up to 400 bp in length, representative clones were not found in the 
shotgun library, following the selection criteria described in the methods. (C) Representative scheme of the type of clones selected from the XAC 
genomic library. The blue region represents the sequence of the pUC19 cloning vector. The region marked by dotted vertical lines bounds the insert 
of the clone. The region where the CDSs do not overlap is marked in yellow, and the corresponding overlap is marked in red. The region with a serrated 
end represents the rupture of the sequence of the gene of interest. Black arrows represent the universal oligonucleotide primer (M13) used for the 
PCR amplification of the insert.Moreira et al. BMC Research Notes 2010, 3:150
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density and artifacts removal (MTM Dens). Array Vision
software allowed the exclusion of bad pixels (pixels
within a section that showed signal intensity either above
or under four median absolute deviations (MADs) of the
signal intensity of all of the pixels in the section).
Results
Construction of XAC DNA microarrays (XACarray)
The selection of clones from the XAC shotgun libraries
allowed for the identification of 4,421 clones, which rep-
resented 3,084 individual CDSs of the XAC genome (Fig-
ure 1A). The remaining 1,405 CDSs, which would
complete the genome, were not selected because they
represented very small CDSs, smaller than 200 bp for
example (Figure 1B), or because they were not physically
found in the shotgun library [6].
Table 1 and Figure 1C present the distribution and pro-
file, respectively, of numbers of CDSs and selected clones,
as well a schematic model of the CDS/insert overlap,
which was used as a reference in the classification of the
clones. It is worth noting that the ideal clones are classi-
fied as overlap type II, because the insert of these clones
as a whole represents a part of the CDS of interest. There-
fore, overlap of other genes or intergenic regions do not
exist. However, this type of clone was the least represen-
tative in the XACarray and consisted of only 292 (11.1%)
of the fixed CDSs (Table 2). For the other three types of
selected clones (I, II and IV), an overlap region of other
CDSs or intergenic regions with the insert was always
present. Of those, the most representative overlap type
was type I (see methods), totaling 1,184 fixed CDSs on
the slide (44.9%) and presenting a insert/CDS of interest
ratio of 0.76 (Table 2).
After the in silico selection, the clones were rearranged
in 47, 96 well plates using a Q-Bot robot™ (Genetix, UK),
and the inserts were amplified by PCR (see methods).
Approximately 5% of the clones were shown to be not via-
ble, and 10% presented an insert with a size different from
that which was predicted (data not shown), suggesting
the existence of probable errors in clone labeling, a com-
mon occurrence in clone library construction, even in
commercial libraries [19]. Moreover, another 15% pre-
sented negative results with respect to their amplifica-
tion. For these reasons, it was necessary to re-sequence
one end of the insert of each of the previously selected
clones in order to confirm the identity of all of the clones.
The sequences were compared to the XAC genome, and
the identity of the clones was corrected when necessary.
Unfortunately, at the end of all the steps described above,
approximately 30% of the initially selected clones (1,326)
Figure 2 (A) Figurative fluxogram of the XACarray construction protocol. The clones were selected from the library, amplified and re-amplified. 
The PCR products were purified and visually analyzed for concentration based on a molecular weight standard created specifically for this purpose 
and by re-sequencing of one of the ends of the insert. The samples were rearranged in 384 well plates and fixed onto the slides. The image demon-
strates the result obtained with the hybridization of the DNA samples labeled with the fluorophores Cy3 and Cy5, highlighting subarray 7, for which 
the monochromatic analysis data demonstrates the quality of the hybridization. (B) Statistical distribution of the products fixed on the XACarray 
based on primary, secondary and tertiary annotation categories [6]. Note that for only two subcategories (III.B.1 and II.D.16), no products were 
represented on the XACarray, and in most of the remaining categories, the total of the genes present (blue bars) exceeds the absent genes (red bar).Moreira et al. BMC Research Notes 2010, 3:150
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could not be used. Thus, at the end of these steps,
expected identity of 2,653 clones were confirmed and this
set was used. They were rearranged again, now in 28 96-
well plates. Although the number of clones was severely
reduced, the microarray contained a set of clones with a
reliable identity. However, after the PCR was performed
to increase the amount of the probe to be immobilized on
the slides, the number of clones was reduced to 2,639,
which represented 58.8% of the XAC genome (Table 2).
To this set of 2,639 PCR products, 121 products derived
from amplifications of genomic DNA sequences using
specific oligonucleotides that were previously acquired
for other experimental proposals were added; these prod-
ucts represented the sequences of genes of particular
interest, including the genes vir, hrp, rpf and gum. Thus,
the 2,760 PCR products were purified (probes), rear-
ranged in 8 384-well plates, and used in the construction
of microarrays as described above.
It is necessary to highlight that the molecular mass pat-
tern obtained from the pUC19 plasmid not only facili-
tated the analysis of the amplified product, but also
demonstrated that this approach was correct. The band-
i n g  p a t t e r n  q u a n t i f i c a t i o n  o f  s o m e  r a n d o m l y  s e l e c t e d
PCR products corresponded to the visual quantifications
that were performed using only the agarose gels (data not
shown).
XACarray validation
For an initial validation of the quality of the XACarray,
hybridization with XAC genomic DNA labeled with dis-
tinct fluorophores was performed. Figure 2A shows the
fluxogram of the XACarray protocol and the hybridiza-
tion images obtained using this probe. Note that the spots
on the slide are practically all yellow in color, which visu-
ally represents the hybridization of probes labeled with
Cy3 and Cy5 in similar quantities. This result can be
observed more rigorously from the monochromatic
images obtained from laser scanning at 550 and 650 nm,
respectively.
The analysis of these images revealed a noticeable sig-
nal above the background noise for 88.5% of the CDSs
represented in the XACarray, a percentage that is equiva-
lent to 2,365 individual CDSs of the XAC genome
(52.7%). Table 2 summarizes the physical features of the
2,670 probes deposited on the XACarray. The probes are
represented in Figure 1C in relation to the type of overlap
of the insert and the average size of these sequences. The
classification of the CDSs regarding their annotation
characteristics is shown in Table 2. The CDS are classified
into two major groups: CDSs previously annotated with a
determined putative function, which represent 63.5% of
the XACarray; and CDSs that compose the hypothetical
group, in this case exclusive hypothetical and conserved
hypothetical in other organisms, which represent the
other 36.5% of the composition of the array.
Quantitatively, the XACarray can be considered to be
representative of the XAC genome, not only for contain-
ing probes that represent more than 50% of all XAC
genes, but also for presenting 83.4% of all of its annota-
tion categories, with more than 50% of the functionally
Table 2: Analysis of the CDSs deposited on the XACarray based on the hybridization signal during the experimental 
validation of the platform.
Type of 
clones
Physical analysis (Fixed PCR products) Annotationc Hybridization signal
Clones
n° (%)
AISa
(bp)
C/Ib
(%)
Function
n° (%)
Hypothetical
n° (%)
Function
n° (%)
Hypothetical
n° (%)
I 1,184 (57.6) 1,487 56.8 631 (53.2) 553 (46.8) 574 (90.9) 485 (87.7)
II 292 (63.1) 1,121 100 235 (80.5) 57 (19.5) 215 (91.5) 52 (91.2)
III 490 (59.3) 1,211 69.9 343 (70.0) 147 (30.0) 323 (94.2) 123 (83.7)
IV 673 (59.9) 1,209 70.5 466 (69.2) 207 (30.8) 436 (93.6) 184 (88.9)
Total 2,639 
(59.7)
1,324 82.1 1,675 
(63.5)
964 (36.5) 1,521 
(90.8)
844 (87.6)
2,365 (89.6)
a AIS (average of insert size).
b C/I (average of overlapping size CDS/Insert)
c Annotation based on Silva et al 2002 [6].
Note that the number of clones that were amplified and positively annotated represent only 59.7% of the total clones initially selected (4,421), 
and that 2,365 of individual CDSs presented a positive hybridization signal, which represent 52.7% of the total annotated CDSs in the genome 
and 89.6% of the fixed products.Moreira et al. BMC Research Notes 2010, 3:150
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Figure 3 XAC genes presented on the XACarray. Those CDs whose products were fixed on the XACarray are marked in red (2,760 in total). The gray 
background highlights the genes annotated as hypothetical or hypothetical conserved. The CDS products highlighted in the figure are presented in 
the additional file 1.Moreira et al. BMC Research Notes 2010, 3:150
http://www.biomedcentral.com/1756-0500/3/150
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annotated genes (Figure 2B). This global vision of repre-
sentation can be observed in detail in Figure 3 and addi-
tional file 1, which correlates the gene map of annotations
to the CDSs fixed on the slide.
Conclusions
In this study, we developed a new and low-cost method to
generate a DNA microarray. Previously, Astua-Monge et
al. [20] used a DNA macroarray, implemented on nylon
membranes and containing probes for 279 XAC genes
associated with pathogenicity and virulence, to investi-
gate genes differentially expressed in a synthetic medium
(XVM2) that simulates in planta conditions. In contrast,
our plataform is the first DNA microarray platform for
XAC that representes more than 50% of all XAC genome
CDSs.
The platform was constructed from shotgun libraries,
previously generated for the genomic sequencing project.
Although the clones of type II are ideal, because they are
restricted to include just an internal fragment of the tar-
get gene, we have made an effort to select clones tha t
would not overlap with other genes. In our array, there
are at least 1,290 clones (~30% of the genome, not count-
ing the ones for which specific primers were designed)
that contain genome fragments that do not overlap any
gene besides the target gene they were selected to repre-
sent. Also, many genes that have fragments in the same
clone will correspond to operons and could, in a first
crude analysis, be regarded as a single expression unit,
with additional experiments clarifying which gene(s) are
indeed relevant. Therefore, our platform can be used to
generate lists of putative differentially expressed genes in
XAC under different physiological conditions.
On the other hand, the presence of overlapping probes
makes it necessary to subsequently validate individual
candidate genes using methods with higher specificity
and sensitivity, like qRT-PCR. Moreover, under most
conditions, some more expensive methods, like designed-
probe chips and RNA-Seq will always provide better
specificity/sensitivity rates and better reproducibility and
such methods should be preferred whenever researchers
have access to them. Functional results using this plat-
form were described in a recent work that use this tool to
validated putative insertion/deletion regions between dif-
ferent and incomplete genomes sequences of other Xan-
thomonas species [21].
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